RAS Mutation Conversion in Bevacizumab-Treated Metastatic Colorectal Cancer Patients: A Liquid Biopsy Based Study

SIMPLE SUMMARY: Recent evidence has been provided that the clonal evolution of mutant RAS colorectal tumors may lead to the negative selection of mutant RAS clones, with the appearance of a time window characterized by the disappearance of RAS mutant clones in plasma. We demonstrate here for the fir...

Descripción completa

Detalles Bibliográficos
Autores principales: Nicolazzo, Chiara, Belardinilli, Francesca, Vestri, Annarita, Magri, Valentina, De Renzi, Gianluigi, De Meo, Michela, Caponnetto, Salvatore, Di Nicolantonio, Federica, Cortesi, Enrico, Giannini, Giuseppe, Gazzaniga, Paola
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8833999/
https://www.ncbi.nlm.nih.gov/pubmed/35159069
http://dx.doi.org/10.3390/cancers14030802

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8833999/
https://www.ncbi.nlm.nih.gov/pubmed/35159069
http://dx.doi.org/10.3390/cancers14030802

Ejemplares similares